Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.

PloS one - 1 Jan 2012

Marteau Theresa M, Aveyard Paul, Munafò Marcus R, Prevost A Toby, Hollands Gareth J, Armstrong David, Sutton Stephen, Hill Chloe, Johnstone Elaine, Kinmonth Ann Louise

Abstract excerpt

BACKGROUND: The behavioural impact of pharmacogenomics is untested. We tested two hypotheses concerning the behavioural impact of informing smokers their oral dose of NRT is tailored to analysis of DNA. METHODS AND FINDINGS: We conducted an RCT with smokers in smoking cessation clinics (N = 633). In combination with NRT patch, participants were informed that their doses of oral NRT were based either on their...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to OPRM1 gene
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nicotine

Share to Receptors, Opioid, mu

Share to Smoking Cessation

Share to Surveys and Questionnaires

Share to Tobacco Use Disorder

Source

Open in PubMed Open full text

Identifiers

PMID: 22509402
DOI: 10.1371/journal.pone.0035249
PMCID: PMC3324463

Genes

OPRM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.PMID 22509402Read ↗

Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence.Semantic proximity Read ↗

Factors influencing the impact of pharmacogenomic prescribing on adherence to nicotine replacement therapy: A qualitative study of participants from a randomized controlled trial.Semantic proximity Read ↗

The association of rs1051730 genotype on adherence to and consumption of prescribed nicotine replacement therapy dose during a smoking cessation attempt.Semantic proximity Read ↗

Smoking cessation treatment: pharmacogenetic assessment.Semantic proximity Read ↗

Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.Semantic proximity Read ↗

Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.Semantic proximity Read ↗

Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment.Semantic proximity Read ↗

Pharmacogenetics of smoking cessation therapySemantic proximity Read ↗

Lack of association of OPRM1 genotype and smoking cessation.Semantic proximity Read ↗

Pharmacogenetic Optimization of Smoking Cessation Treatment.Semantic proximity Read ↗

Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial.Semantic proximity Read ↗

Pharmacogenetics and nicotine addiction treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.